Company intelligence / Profile preview

PSN Group

Charlottesville, Virginia, United States

Ownership: Private
Employees: ~235
Development stage: Other

Overview

PSNResearch specializes in advanced therapy clinical development, including first-in-human, immuno-oncology, and orphan indications. They support drug and medical device developers with end-to-end clinical research, regulatory affairs, medical writing, and trial execution. They have contributed to pivotal trials, FIH studies, and regulatory filings that enabled product approvals in major global markets.[6][7][9]

Therapeutic areas: OncologyImmunologyNeurologyRare Diseases
Modalities: Small moleculeMonoclonal antibodyBiologicCell therapy
Industry: Contract Research Organization

Partnerships

Global biotechnology, medical device, and pharmaceutical companies (not specifically named in available public sources)

Beyond the preview

Go deeper on PSN Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSN Group.

Explore the full profile